Injury rates and patterns in French male professional soccer clubs: a comparison between a regular season and a season in the Covid-19 pandemic.

This study investigated time-loss injury occurrence and patterns between the first season (2020/21, S2) completed during the Covid-19 pandemic (longer pre-season following cancellation of the 2019/20 season but shorter duration) and a regular season (2018/19, S1) in French Ligue 1 and 2 professional soccer clubs. Epidemiological data were prospectively recorded in a national injury database by each club's physician. In all clubs combined, the mean number of injuries per club was 31.5 and 36.6 in S2 and S1, respectively (-13.9%). Overall match injury incidence (per 1000 hours) in all clubs combined was lower in S2 versus S1 (22.23 vs 25.96, p < 0.01). In Ligue 1 clubs alone, match-play incidences for injury overall (24.92 vs 29.42), muscle strains (10.59 vs 13.24) and strains specifically in the hamstring region (4.52 vs 6.22) were lower in S2 versus S1 (all p < 0.05). No differences in the incidence of match injuries affecting the ankle and knee regions were observed. Changes in the 2020/21 season structure and duration owing to the Covid-19 pandemic seem not to have had a negative effect on injury occurrence and patterns in French professional soccer clubs.

Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 season.

OBJECTIVES: To describe the epidemiology of COVID-19 in French professional football players, and to compare the infection incidence with the general population across the first three waves. METHODS: During the 2020-2021 season, all professional football players (n = 1217) in the two primary French leagues underwent weekly testing for SARS-CoV-2 infection by nasopharyngeal PCR, in combination with rigorous infection control measures. RESULTS: Among all players, 572 (47%) tested positive at least once, with no COVID-19-related death or hospital admission. Monthly incidence estimates in players ranged from 1486 to 6731 per 100,000 individuals, i.e. 2-17 times higher than incidence estimates in the general population in France during the study period. CONCLUSION: Almost 50% of professional football players developed SARS-CoV-2 infection during the 2020-2021 season in France, with no severe complication.

A retrospective analysis of all-cause and cause-specific mortality rates in French male professional footballers.

This study retrospectively compared all-cause and cause-specific mortality in French male professional football players with data from France's national population. Altogether, 6114 individuals born in Metropolitan France or in one of its overseas territories who played at least one competitive match in France's professional football championships between January 1, 1968 and December 31, 2015, were identified and followed up for vital status obtained from a national reference database until December 31, 2015. Data on all-cause and cause-specific mortality were subsequently compared to the expected number of deaths for the national population after standardization for the year, age, and sex. Ratios between observed and expected deaths provided standardized mortality ratios (SMR) along with 95% confidence intervals (95% CI). Linear trends were investigated using the Poisson trend test. Altogether, 662 player deaths were observed. All-cause mortality overall was lower than that of the national population (SMR: 0.69, 95% CI 0.64-0.75). An excess of deaths from dementia was observed in the players (SMR: 3.38, 95% CI: 2.49-4.50) whereas mortality from diseases of the nervous (SMR: 0.64, 95% CI: 0.35-1.08) and cardiovascular systems (SMR: 0.82, 95% CI: 0.70-0.96), and cancer (SMR: 0.67, 95% CI: 0.58-0.76) was lower. Lower overall mortality and that owing to common cardiovascular and cancer-related diseases were reported in French professional football players compared to France's national population. In line with previous studies, however, excess mortality from dementia was observed in the players. Career length was not associated with all-cause or cause-specific mortality. Prospective matched-cohort studies are necessary to identify the neurologic impact of participation in professional football.